Authors
Loading...
Cost-benefit analysis compares productivity gains from IPT and fluoxetine in treating depression and PTSD in primary care, highlighting FLX's better outcomes.
Olwanda et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: